Skip to content Skip to sidebar Skip to footer
Tirzepatide improves heart health and function in obese HFpEF patients

Tirzepatide improves heart health and function in obese HFpEF patients

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure events and cardiovascular death, and improved health status and physical function in comparison to participants taking placebo, according to late-breaking science presented today at…

Read more

Fed pulls half of credit available from BTFP, engineering a potential banking crash to be thrown in Trump’s lap – NaturalNews.com

Fed pulls half of credit available from BTFP, engineering a potential banking crash to be thrown in Trump’s lap – NaturalNews.com

Fed pulls half of credit available from BTFP, engineering a potential banking crash to be thrown in Trump’s lap The Fed's latest move has some observers warning that we could be about to experience another crash. X user @FinanceLancelot cautioned: “The Federal Reserve's emergency BTFP dropped by a shocking $30 billion this week, leaving only $26…

Read more

SGLT2 inhibitor canagliflozin shown to improve kidney oxygenation in diabetes patients

SGLT2 inhibitor canagliflozin shown to improve kidney oxygenation in diabetes patients

Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An Osaka Metropolitan University-led research group has investigated how such drugs maintain kidney health. Known as SGLT2 (sodium-glucose cotransporter-2) inhibitors, the drugs are used to treat type 2…

Read more

the Kick-ass Multipurpose WordPress Theme

© 2025 Kicker. All Rights Reserved.